When was NeoSoma founded?

NeoSoma was founded in 2019 and raised its 1st funding round 1 year after it was founded.

Where is NeoSoma located?

NeoSoma is headquartered in Boston, United States.

Who is the current CEO of NeoSoma?

Ken Kolodziej of NeoSoma. They have also founded 1 company.

How many employees does NeoSoma have?

As of Sep 30, 2026, the latest employee count at NeoSoma is 12.

Is NeoSoma a funded company?

NeoSoma is a funded company, having raised a total of $10.2M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Nov 20, 2020.

When was the latest funding round of NeoSoma?

NeoSoma's latest funding was a $***** Series B round on Mar 18, 2026, with participation from 0 investor. Its primary sector is Healthcare IT. In United States, the Healthcare IT sector has seen $6.6B in funding in 2026 to date.

Where does NeoSoma rank among its competitors?

NeoSoma ranks 4th amongst 90 active competitors, of which 23 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was DeepWise, which secured an undisclosed amount in Jun, 2026.

Who are the top competitors of NeoSoma?

NeoSoma's top competitors include Median Technologies, Avenda Health and DeepWise. Among them, DeepWise secured the most recent funding round in June, 2026.

NeoSoma - 2026 Company Profile, Team, Funding & Competitors

NeoSoma is a series B company based in Boston (United States), founded in 2019 by Ken Kolodziej and Aly H Abayazeed. It operates as a Provider of an AI-based image analysis and decision-making platform for neurooncologist. NeoSoma has raised $10.2M in funding. The company has 90 active competitors, including 23 funded and 6 that have exited. Its top competitors include companies like Median Technologies, Avenda Health and DeepWise.

Company Details

Provider of an AI-based image analysis and decision-making platform for neurooncologist. The company has developed an AI-enabled neurooncology platform that assists doctors in clinical management. The company has developed platforms like RANO (Response Assessment Neuro-oncology Criteria) that are made for clinical decision making. It provides 2D image analysis tools for brain tumors. There is an automated version called Neosoma-Glioma Automates RANO. The platform has a medical imaging technology for precise analysis of patients' reports and information. Its products are based and developed on MRI sequences for analysis and modeling.

Website: www.neosomainc.com/
Social
Email ID: *****@neosomainc.com

Key Metrics

Founded Year

2019

Location

Boston, United States

Stage

Series B

Total Funding

$10.2M in 5 rounds

Latest Funding Round

Series B, Mar 18, 2026, $*****

Ranked

4^th among 90 active competitors

Employee Count

12 as on Sep 30, 2026

Similar Companies

Median Technologies & 79 more

View NeoSoma's full profile

NeoSoma is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
NeoSoma, Inc CIN: 833789214 , United States, Active	Dec 31, 2018	-	-	-

NeoSoma has raised a total funding of $10.2M over 5 rounds. Its first funding round was on Nov 20, 2020.

Here is the list of recent funding rounds of NeoSoma:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 18, 2026	9064198	Series B	1450129	5309294	2687608	9803437
Dec 24, 2024	5959520	Series A	6322652	1255555	7396055	4619315
Jul 11, 2024	3163235	Series A	9416076	6877689	8427210	5599298

Access funding benchmarks and valuations. Sign up today!

View details of NeoSoma's funding rounds and investors

The founders of NeoSoma are Ken Kolodziej and Aly H Abayazeed. Ken Kolodziej is the CEO of NeoSoma.

Here are the details of NeoSoma's key team members:

Ken Kolodziej: Co-Founder & CEO of NeoSoma and founder of 2 other companies, String Enterprises and String Automotive.
Aly H Abayazeed: Former Co-Founder of NeoSoma.

View details of NeoSoma's Founder profiles and Board Members

NeoSoma's employee count trend

NeoSoma has 12 employees as of Sep 26. Here is NeoSoma's employee count trend over the years:

Uncover NeoSoma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of NeoSoma include Median Technologies, Avenda Health and DeepWise. Here is the list of Top 10 competitors of NeoSoma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Median Technologies 2002, Valbonne (France), Public	Developer of medical imaging software for clinical trials and diagnostics	$5.28M	Matignon Finances, Lion Point Life Science Partners ... & 13 others	62/100
2nd	Avenda Health 2017, Santa Monica (United States), Series B	Developer of a focal therapy system to treat prostate cancer	$31M	VCapital, Plug and Play Tech Center & 3 others	61/100
3rd	DeepWise 2017, Beijing (China), Series D	Developer of AI-based radiology image solutions primarily for cancer diagnosis	$115M	Legend Capital, CICC Capital & 18 others	59/100
4th	NeoSoma 2019, Boston (United States), Series B	Provider of an AI-based image analysis and decision-making platform for neurooncologist	$10.2M	-	58/100
5th	Onc.ai 2020, San Carlos (United States), Series A	AI-based cancer treatment and diagnosis platform for healthcare providers	$31M	Accomplice, MassMutual & 12 others	57/100
6th	LPixel 2014, Tokyo (Japan), Series A	Image analysis tools using artificial intelligence	$7M	JAFCO Group, Mistletoe & 6 others	56/100
7th	Sycai Medical 2020, Barcelona (Spain), Seed	Provider of AI-based image diagnosis tool for healthcare professionals	$3.98M	Athos Capital, Ship2B Ventures & 5 others	54/100
8th	SimBioSys 2016, Chicago (United States), Series A	Provider of AI-based decision-making and cancer diagnosis tool for healthcare professionals	$20.2M	Northpond Ventures, Genoa Ventures & 4 others	54/100
9th	Imaging Biometrics 2007, Waukesha (United States), Acquired	Provider of an AI-based medical image analysis software for healthcare professionals	$24.1K	National Cancer Institute, Braveheart Investment Group ... & 3 others	52/100
10th	Koios Medical 2012, New York (United States), Series B	Provider of artificial intelligence based ultrasound to diagnose cancer	$15.9M	Mitsui, Bold Brain & 1 others	50/100